Advertisement

Topics

Anatara and Zoetis to Negotiate Terms of an International Detach® Commercial Agreement

08:08 EDT 21 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Key points: Global animal health company Zoetis has exercised its option to negotiate a commercial agreement for the worldwide development, distribution and marketing of Detach®, per the Exclusive...

Other Sources for this Article

General inquiries
Anatara Lifesciences
Dr Mel Bridges, +61 (0) 413 051 600
Chairman & CEO
mbridges@anataralifesciences.com
or
Media inquiries
IR Department
Jane Lowe, +61 (0) 411 117 774
Managing Director
jane.lowe@irdepartment.com.au

NEXT ARTICLE

More From BioPortfolio on "Anatara and Zoetis to Negotiate Terms of an International Detach® Commercial Agreement"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...